Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F, Jia Y, Zheng X, Shao D, Zhao Y, Wang Z, Dawulieti J, Liu W, Sun M, Sun W, Pan Y, Cui L, Wang Y, He K, Zhang M, Li J, Dong WF, Chen L.
Zhang F, et al. Among authors: zheng x.
Acta Biomater. 2019 Dec;100:352-364. doi: 10.1016/j.actbio.2019.09.034. Epub 2019 Sep 26.
Acta Biomater. 2019.
PMID: 31563690